A Single-Residue Switch for High Temperature Dependence of Thermal TRPV3 Channels  by Liu, Beiying & Qin, Feng
Sunday, February 8, 2015 125aand persistent pain. Antagonists of human TRPV1 (hTRPV1) represent a
novel therapeutic approach for the treatment of pain. Developing various
antagonists of hTRPV1, however, has been hindered by the unavailability
of a 3D structure of hTRPV1. Recently, the structure of rat TRPV1 have
been reported and it shares 85.7% sequence identity with hTRPV1. In
the present work, we constructed and reported a 3D homology tetramer
model of hTRPV1 based on the cryo-EM structures of rTRPV1. Molecular
dynamics (MD) simulations, energy minimizations, and prescreen were
applied to select and validate the best model of hTRPV1. The predicted
binding pocket of hTRPV1 consists of two adjacent monomers, which
were congruent with the experimental data and the cyro-EM structures of
rTRPV1. The detailed interactions between hTRPV1 and its antagonists
or agonists were characterized by molecular docking. Conformational
changes of hTRPV1 upon antagonist/agonist binding were also explored
by MD simulation. The different movements of compounds led to different
conformational changes of monomers in hTRPV1, indicating that TRPV1
works in a concerted way. We observed that the selective filter was open
when hTRPV1 bound with an agonist during MD simulation. For the lower
gate of hTRPV1, we observed large similarities between hTRPV1 of
agonist-bound and of antagonist bound. A five-point pharmacophore model
based on several antagonists was developed and the structural model was
used to predict new antagonists for hTRPV1. By using the 3D TRPV1
structure model above, we have performed in-silico screening and identified
candidate compounds which are currently being characterized both for
binding affinity and for functional activity on human TRPV1 (NIH
R01DA025612 and P30DA035778).
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Phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) has been recognized as an
important activator of certain transient receptor potential (TRP) channels.
More specifically, TRPV1 is a pain receptor activated by a wide range of
stimuli. However, whether or not PI(4,5)P2 is a TRPV1 agonist remains open
to debate. Utilizing a combined approach of mutagenesis and molecular
modeling, we identified a PI(4,5)P2 binding site located between the TRP
box and the S4-S5 linker. At this site PI(4,5)P2 interacts with the amino acid
residues R575 and R579 in the S4-S5 linker and with K694 in the TRP box.
We confirmed that PI(4,5)P2 behaves as a channel agonist and found that
R575, R579 and K694 mutations to alanine reduce PI(4,5)P2 binding affinity.
Additionally, in silico mutations R575A, R579A and K694A showed that the
reduction in binding affinity results from the delocalization of PI(4,5)P2 in
the binding pocket. Molecular dynamics simulations indicate that PI(4,5)P2
binding induces conformational rearrangements of the structure formed by
S6 and the TRP domain, which leads to the opening of the lower TRPV1 chan-
nel gate.
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Pain accompanies several diseases including arthritis, cancer, diabetes, and
often manifests as a disease itself. Currently, narcotic and non-narcotic drugs
that are used to treat pain have several unwanted side effects due to their
addiction, use dependence, and systemic side effects. A potential solution is
to develop a target site-specific magnetic nanoparticle based delivery of anal-
gesics. Transient Receptor Potential Vanilloid 1 (TRPV1; capsaicin receptor)
is a non-selective cation channel protein, which mediates nociceptive pain and
inflammation and is a target to develop therapeutics against chronic pain.
Capsaicin, an ingredient of hot chili peppers, desensitizes TRPV1 and inhibits
noxious pain. Here, we present the development and characterization of
capsaicin magnetic nanoparticles (CMN) for site-specific pain therapeutics.
Poly-L-lactide coglycollide (PLGA) coated CMN (PCMN) was prepared bysolvent evaporation/coprecipitation technique and determined the size of
CMN by transmission electron microscopy. Further, we determined the
drug loading, encapsulation efficiency and pharmacokinetic release profiles
of capsaicin from PCMN in vitro and examined the ability of PCMN to
activate TRPV1, by intracellular Ca2þ imaging. Thermogram of CMN and
crystalline nature of capsaicin were determined by differential scanning calo-
rimetry and x-ray diffraction techniques, respectively. Next, we analyzed the
intracellular localization of nanoparticles using fluorescein as a model drug.
Finally, we characterized the anti-nociceptive potential of PCMN by intra-
plantar injection of PCMN in mice model of inflammation and pain. Our
data demonstrate that PLGA coated CMN can be developed as a novel site-
specific analgesic. Currently, we are investigating the site-specific action of
PCMN under the influence of an external magnetic field. This novel method
of drug-delivery will revolutionize therapeutics, since it will prevent the un-
desired side effects.
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In addition to pain sensation, both thermal regulation and thermosensation are
thought to be influenced by TRPV1 channel functioning. Involvement of
TRPV1 in these latter physiological functions became clear during pharma-
ceutical development of selective TRPV1 antagonists for the treatment of
chronic painful conditions. The majority of TRPV1 antagonists that have
been progressed into clinical trials were reported to increase body temperature
(hyperthermia) in healthy humans. Currently, hyperthermia is a major concern
in pharmaceutical development of TRPV1 antagonists. We therefore sought
of an in-vitro method to identify compounds with a low hyperthermic potential
early in the drug discovery process. Using whole-cell patch clamp electro-
physiology on human TRPV1 expressing CHO cells, we performed kinetic
measurements of dissociation from the receptor of known hyperthermic
(AMG517 and ABT102) and non-hyperthermic (SB705498) TRPV1 antago-
nists. We found that AMG517 and ABT102, two hyperthermic compounds,
exhibited slow off- (dissociation) rates when channels were activated by
capsaicin. Conversely, the non-hyperthermic compound SB705498, showed
a significantly faster rate of dissociation from the receptor. Finally, we as-
sessed an in-house proprietary antagonist V116517 which demonstrated
significant separation between analgesic efficacy and hyperthermia. Once
again, this compound displayed a faster off-rate as compared to the hyperther-
mic compounds.
With these initial findings we hypothesize that the dissociation rate of an
antagonist from the TRPV1 channel is an important parameter in determining
a compound’s effect on thermal regulation and thermosensation. Antagonists
with a fast off-rate may allow endogenous ligands to interact with the TRPV1
channel and thereby fulfil its physiological role in body temperature regula-
tion while still effectively modifying pain signaling. In conclusion, our find-
ings suggest that in vitro kinetic measurements early in the drug discovery
process may be a useful means of identifying non-hyperthermic TRPV1
antagonists.
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Thermal TRP channels, a group of ion channels from the transient receptor
potential family, play important functions in pain transduction and thermal
sensation. The channels are directly activated by temperature, with strong
temperature dependence. However, how temperature gates these channels re-
mains poorly understood. One characteristic feature of some thermal TRP
channels is hysteresis of gating. This is perhaps most prominent in vanilloid
receptor TRPV3. The channel is initially only responsive to extreme heat
with low activity, and only after repeated stimulation it becomes vigorously
responsive to warm temperatures. Importantly, the hysteresis of activation is
accompanied with a profound loss of the high temperature dependence of
the channel, suggesting that the hysteresis involves structural changes in tem-
perature sensing. Elucidation of such changes will therefore provide an oppor-
tunity to unravel the molecular mechanism underlying temperature sensing of
thermal channels. Here we examine the molecular basis underlying hysteresis
of heat activation of TRPV3. We show that the hysteresis is mediated by an N
terminal domain proximal to membranes, the same region that we have
126a Sunday, February 8, 2015previously identified for temperature sensing in heat sensitive vanilloid recep-
tors. Upon exchange of the region, the heat activation of the channel becomes
reversible and the temperature dependence becomes considerably reduced as
the wild type channels after sensitization. Interesting much of the hysteresis
effect can be attributed to a single residue near the TRP box. The position
of the residue suggests a mechanism of temperature-dependent gating of ther-
mal TRP channels involving an intracellular region assembled around the
TRP domain.
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The transient receptor potential channel TRPV4 is a calcium conducting,
osmosensitive cation channel and expressed in motoneurons and skeletal
muscles. In mouse muscle fibers TRPV4 forms or contributes to a mechano-
sensitive cation channel. The molecular architecture of this channel is still
unclear. Since mechanosensitive cation channels can be blocked by the
peptide toxin GsMTx-4, we studied whether TRPV4 itself is sensitive to
GsMTx-4. To this end a TRPV4-YFP construct was functionally expressed
in HEK-293 cells. Intracellular Ca2þ concentrations were monitored with
the fluorescent Ca2þ indicator Fura-2 and the data presented as Fura-2 fluo-
rescence ratios after alternate excitation at 340 and 380 nm. Non-transfected
cells (n¼47) had an average resting ratio of 0.39 (range 0.38 and 0.42),
while TRPV4 transfected cells (n¼524) showed on average an increased
fluorescence ratio of 1.11 ranging from 0.44 to 2.71. Application of 4a-
PDD (5 mM), a known TRPV4 activator, increased the fluorescence ratios
in the HEK cells to 1.72, 1.73 and 1.77 with a peak or plateau at 1-3 min
(n¼13-19 cells, each experiment). The effect of 4a-PDD could be reversed
within about 10-30 min by application of the TRPV4 blocker HC-067047
(1 mM) and GsMTx-4 (5 mM). The final resting ratios were 0.77 for HC-
067047 and 1.16 for GsMTx-4. At a concentration of 1 mM the toxin was
almost ineffective. The results indicate that TRPV4 activity can be inhibited
by GsMTx-4. However, the required concentration of the toxin is higher
than those required for inhibition of TRPC6, TRPC1 and voltage-gated so-
dium channels. The results support the view that TRPV4 may be part of me-
chanosensitive cation channels that are sensitive to the channel blocker
GsMTx-4.
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In excitable cells, ion channel responses to patterned stimuli shape cellular
behavior by regulating the duration, shape, and frequency of action potentials.
We have investigated the behavior of voltage-gated potassium (Kv) channels
subjected to repetitive stimuli, with a particular focus on the delayed rectifier
Kv1.2. Genetic deletion of this subunit results in complete mortality within
two weeks of birth in mice, highlighting a critical role for Kv1.2. To this
end, we have examined a unique property of Kv1.2, previously described as
‘‘prepulse potentiation’’. In this study, we demonstrate that this property en-
ables Kv1.2 channels to exhibit use-dependent activation during trains of brief
depolarizations, causing dramatic increases in elicited current. Importantly,
Kv subunits may assemble into heteromeric channels in the central nervous
system, generating diversity of function and sensitivity to signaling mecha-
nisms. We demonstrate that other Kv1 channel types do not exhibit use-
dependent activation, but this property is conferred when they co-assemble
with Kv1.2. These results are apparent in transfected mammalian cell lines
as well as in tityustoxin-sensitive currents recorded from primary cultures
of dissociated hippocampal neurons. Importantly, Kv1.2 assembly with
different subunits can generate diverse current phenotypes with variable
use-dependent activation or rundown. These findings illustrate that use-
dependent activation is a unique property of Kv1.2 which persists in hetero-
meric channels and may influence physiological function of hippocampal
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In recent years, cholesterol emerged as a major regulator of ion channel func-
tion. The most common effect of cholesterol on ion channels is a decrease in
channel activity. Here we focus on G-protein gated inwardly rectifying potas-
sium (GIRK or Kir3) channels that play an important role in regulating mem-
brane excitability in cardiac, neuronal and endocrine cells.
We have recently shown that unexpectedly cholesterol enrichment up-
regulates GIRK activity in atrial myocytes. In accordance, we also observed
elevated GIRK currents in cholesterol-enriched Xenopus oocytes expressing
the GIRK1/GIRK4 heteromers, the two pore-forming subunits expressed in
the heart. Interestingly, whereas similarly to the heteromer GIRK1/GIRK4,
the highly active homomeric pore mutant GIRK4* (GIRK4_S143T) was
also enhanced by cholesterol, GIRK1* (GIRK1_F137S) was suppressed
by cholesterol. Thus, in this study, we focused on identifying what deter-
mines whether a channel would be enhanced or suppressed by cholesterol.
Although the major difference between these channels is in the cytosolic
domain, our data showed that the impact of cholesterol did not depend on
the extended C-terminus of GIRK1 as compared with GIRK4. Rather, our re-
sults show that a transmembrane region that includes residues from both the in-
ner and outer alpha helices of the channel determines the impact of cholesterol
on the channel.
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The Solute Carrier 4 (SLC4) family are integral membrane cotransporters that
reabsorb or secret anions across the basolateral membranes throughout the
body, especially the kidney, eye, and red blood cells. Defects of SLC4A4
(NBCe1-A) lead to type-II acidosis and myriad ocular abnormalities; those
of SLC4A1 (AE1) causes type-I acidosis and sperocytosis. We demonstrate
that SLC4s form patches in the membrane of proximal tubule cells, corneal
endothelial cells, and Xenopus oocytes. This new discovery of homophilic in-
teractions or self-associations was initially suggested from our biophysical
studies of the N-terminal domain of NBCe1-A (Nt) in solution, and by others
studying the transmembrane domain (TMD) of AE1. The role and mecha-
nisms of self-associations are further investigated, with insight into the role
of the devastating R298S hereditary mutation found in type-II RTA afflicted
individuals. We use confocal-microscopy imaging of fluorescently-tagged
NBCe1-A and NBCe1-A-R298S molecules expressed in the aforementioned
cells types and from in-depth biophysical studies of their Nts, including our
Nt crystal structure at 2.4-A˚ resolution, melting-temperature, and homodimer
dissociation constant (KD) analyses by composition-gradient multi-angle light
scattering (CG-MALS). The structure reveals that the Nt dimerizes by two in-
terlocking arms and contains two variable sequence regions, one at the
extreme N terminus (V1) and another in the middle (V2). The V1 domains
are flexible segments that gate substrate entry into the Nt, and that the V2
are large solvent accessible loops that extend ~20 A˚ from the core Nt struc-
ture. Truncation mutants were rationally generated, and surface plasmon reso-
nance (SPR) was used to investigate their roles in self-association. Based on
these findings, we discuss the role of clustering in HCO3- sensing and trans-
port in health and provide insight to the pathogenic processes observed in pa-
tients with point mutations.
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The cystic fibrosis transmembrane conductance regulator (CFTR) is an anion
channel which is expressed at the apical surface of many secretory epithelia.
CFTR and reactive oxygen species (ROS) are both involved in innate im-
mune responses against bacterial pathogens, however the link between
them during host defense is not well understood. Here we study the surface
expression and dynamics of CFTR in epithelial cells during protein kinase C
(PKC) stimulation using fluorescence microscopy and k-space image correla-
tion spectroscopy (kICS). kICS analysis was used to measure the confined
